Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria

Table 2

Change of urticaria control test and urticaria activity score 7.

	Baseline	3rd month	6th month	p Value
	Median (Q1–Q3)	Median (Q1–Q3)	Median (Q1–Q3)
UAS7^†	24.5 (16–42)^a	2 (0–6)^b	1.5 (0–8)^b
UCT^‡	3.50 (0–7)^b	14.50 (11–16)^a	15 (12–16)^a

Note: Friedman test. ^†Urticaria activity score 7, ^‡Urticaria control test, ^a,bDifferent letters indicate which group the difference originates from (Dunn’s test).